Kura Oncology Inc (KURA) Hedge Fund Ownership (Q1 2026)

Q: Is it too late to buy Kura Oncology Inc (KURA) following the 2026 Q2 hedge fund 13F filings?

As of today, KURA has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), KURA gained -3.7% vs +5.7% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Kura Oncology Inc (KURA)

214 + Investors. Track Smart Money conviction in KURA. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — KURA

Based on 215 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added KURA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

215 hedge funds hold KURA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

📶

Steady growth — +16% more funds vs a year ago

fund count last 6Q

+30 new funds entered over the past year (+16% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.

🟠

More sellers than buyers — 48% buying

103 buying113 selling

Last quarter: 113 funds reduced or exited vs 103 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

⚠️

Fewer new buyers each quarter (-8 vs last Q)

new funds entering per quarter

Funds opening this position for the first time: 27 → 44 → 42 → 34. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.

🔒

48% of holders stayed for 2+ years

■ 48% conviction (2yr+) ■ 28% medium ■ 24% new

104 out of 215 hedge funds have held KURA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💎

Buying through price weakness — shares -1%, value -23%

Value

-22%

-1%

Last quarter: funds added -1% more shares while total portfolio value only changed -23%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

➡️

Steady discovery — ~34 new funds/quarter

38 → 27 → 44 → 42 → 34 new funds/Q

New funds entering each quarter: 27 → 44 → 42 → 34. Consistent flow of new institutional buyers without clear acceleration or slowdown.

🏛️

Veteran-anchored — 58% veterans vs 28% newcomers

■ 58% veterans ■ 13% 1-2yr ■ 28% new

Entry-cohort mix of 223 holders: 130 (58%) are 2+ year veterans, 30 entered 1–2 years ago, and 63 (28%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

✅

Strong quality — 27% AUM from major funds

27% from top-100 AUM funds

42 of 215 holders rank in the top 100 by AUM, accounting for 27% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

4.0

out of 10

Moderate Exit Risk

Exit risk score 4.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	214	210	1.9%
13F Shares	85M	86M	-1.13%
Total Value	$687M	$891M	-22.89%
New Positions	33	41	-8
Increased Positions	67	88	-21
Closed Positions	29	30	-1
Reduced Positions	81	53	+28
Total Calls	4	4	-
Total Puts	4	5	-20.0%
PUT/CALL Ratio	1.0	1.25	Neutral

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

214

210

1.9%

13F Shares

85M

86M

-1.13%

Total Value

$687M

$891M

-22.89%

New Positions

-8

Increased Positions

-21

Closed Positions

-1

Reduced Positions

+28

Total Calls

Total Puts

-20.0%

PUT/CALL Ratio

1.0

1.25

Neutral

Institutional Holders (2026 Q2)

214 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in KURA. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 KURA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Alethea Capital Management, LLC	9.85%	2,167,938	$23.8M
2	Ishara Investments LP	2.23%	276,750	$3.0M
3	1492 Capital Management LLC	1.51%	467,153	$5.1M
4	NAN FUNG TRINITY (HK) Ltd	1.27%	1,174,880	$12.9M
5	Sector Gamma As	1.03%	433,012	$4.8M
6	Act Capital Management, LLC	0.64%	88,900	$975K
7	Rhenman & Partners Asset Management AB	0.61%	591,500	$6.5M
8	Sectoral Asset Management Inc	0.55%	71,480	$784K
9	nVerses Capital, LLC	0.44%	26,023	$285K
10	Rosalind Advisors, Inc.	0.41%	100,000	$1.1M
11	Virtus Investment Advisers, LLC	0.33%	128,495	$1.4M
12	Deep Track Capital, LP	0.32%	1,978,565	$21.7M
13	Knott David M Jr	0.31%	52,767	$579K
14	Xcel Wealth Management, LLC	0.24%	90,983	$998K
15	Pavaki Capital Management LLC	0.22%	30,000	$312K
16	Hennion & Walsh Asset Management, Inc.	0.18%	568,845	$6.2M
17	Fox Run Management, L.L.C.	0.09%	49,513	$543K
18	Flower City Capital	0.09%	18,000	$197K
19	Royce & Associates LP	0.05%	609,985	$6.7M
20	Pale Fire Capital SE	0.04%	56,600	$621K
21	Aaron Wealth Advisors LLC	0.04%	67,455	$740K
22	OP Asset Management Ltd	0.03%	291,880	$3.2M
23	Martingale Asset Management L P	0.03%	128,892	$1.4M
24	Tema Etfs LLC	0.03%	93,761	$1.0M
25	Quarry LP	0.03%	34,054	$374K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Kura Oncology Inc (KURA)

What does the Smart Money Trend signal show for KURA?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added KURA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for KURA?

More sellers than buyers — 48% buying: Last quarter: 113 funds reduced or exited vs 103 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for KURA holders?

Strong quality — 27% AUM from major funds: 42 of 215 holders rank in the top 100 by AUM, accounting for 27% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held KURA?

48% of holders stayed for 2+ years: 104 out of 215 hedge funds have held KURA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Kura Oncology Inc (KURA) following the 2026 Q2 hedge fund 13F filings?

As of today, KURA has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), KURA has gained -3.7% vs +5.7% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Kura Oncology Inc (KURA)

Smart Money Signals — KURA

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Steady growth — +16% more funds vs a year ago

More sellers than buyers — 48% buying

Fewer new buyers each quarter (-8 vs last Q)

48% of holders stayed for 2+ years

Buying through price weakness — shares -1%, value -23%

Steady discovery — ~34 new funds/quarter

Veteran-anchored — 58% veterans vs 28% newcomers

Strong quality — 27% AUM from major funds

Institutional Sentiment Summary — KURA

Hedge Fund Ownership: KURA

Market Analysis: KURA

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: KURA

Is It Too Late to Buy Kura Oncology Inc (KURA) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: KURA

Statistics: KURA

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Kura Oncology Inc (KURA)

Welcome to 13Foresight!